Skip to main content

Advertisement

Table 2 Summary of outcome measures

From: Benefits of home-based multidisciplinary exercise and supportive care in inoperable non-small cell lung cancer – protocol for a phase II randomised controlled trial

  Time point
Outcomes Baseline Post-program
(9-weeks)
4-months (telephone) 6-months
Primary outcome
 6MWD  
Key secondary outcomes
 Physical Activity
  Accelerometry  
  IPAQ  
 Strength
  HHD quadriceps  
  HGD  
Secondary outcomes
 HRQoL
  FACT-L  
  AQoL  
 PAAI  
 BREQ-2  
 MDASI-LC  
 HADS  
 CD-RISC  
 Health economic questionnaire  
 Qualitative interviews (subset)     
Exploratory outcomes (subset)
 Venous blood sample   
 Quadriceps size and echogenicity   
  1. 6MWD six minute walk distance, IPAQ International Physical Activity Questionnaire, HHD hand-held dynamometry, HGD handgrip dynamometry, HRQoL health-related quality of life, FACT-L Functional Assessment of Cancer Therapy-Lung, AQoL Assessment of Quality of Life, PAAI Physical Activity Assessment Inventory, BREQ-2 Behavioural Regulation in Exercise Questionnaire Version 2, MDASI-LC MD Anderson Symptom Inventory-Lung Cancer, HADS Hospital Anxiety and Depression Scale, CD-RISC Connor Davidson Resilience Scale. Survival, collected until 3-years, and serious and minor adverse events will be collected until 6-months